Simply Put: COVAX funds
Re-embrace democracy, Free World
The pandemic response will become truly global only when the vaccine becomes a global good
COVID vaccines pillar COVAX to wind down by year-end, left with billions unspent
Vaccine delivery to shift to regular programmes
What will help us live with COVID-19 in the future?
A combination of both vaccines or drugs would be needed
A granular look at UK’s COVID-19 ‘red list’ shows why it’s deeply flawed
Sudan is on the red list whereas South Sudan is not.
COVID-19 vaccines: India needs to rise
India has to work hard to defend its position as the global hub of vaccine production
Only 15% COVID-19 vaccine doses pledged by countries have materialised: WHO chief
Around 50 countries, mostly in Africa, will lag behind the global target of vaccinating 10% population in each country by September
COVID-19: Can India vaccinate all adults in 4 months?
COVID-19: India trips on its patent waiver proposal
New Delhi has not backed its WTO proposal to suspend intellectual property rights on COVID-19 pharma products with robust action
Rich countries must share their vaccines with poor ones quickly: WHO panel
Vaccine distribution to low-income countries falls short of 1 billion target, former panel leaders, Ellen Johnson Sirleaf and Helen Clark, said
Lateral thoughts: COVID-19 vaccines and a game of chance
Would you be compensated for adverse reactions to the COVID-19 vaccines?
Omicron threat: How fast is India vaccinating against COVID-19
Rate too slow to meet target of vaccinating every eligible by end of year. The question is: Can Omicron further derail India’s fight …
COVID-19: Only 17% of Africans will now be vaccinated by year-end
Africa faces a shortfall of 470 million COVID-19 vaccine doses, says WHO
COVID-19 vaccine update: How much is the world lagging behind in vaccination
COVAX expects to reach its target of two billion doses in the first quarter of 2022
COVID-19 in 2023 and beyond — why virus trends are more difficult to predict three years on
In total, 13 billion vaccine doses have been administered — but not equitably.
What South Africans should know, but don’t, about government’s COVID-19 vaccine procurement
Uncertainty remains around the exact role of South Africa’s nine provinces, each with its own legislature and executive council, on …
WHO calls for moratorium on booster till 2021-end, ‘additional’ dose for high risk population
Currently, 20 per cent of the available vaccines are being used as boosters
Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production
Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …
COVID-19 vaccine for all: WHO releases guidelines for manufactures, countries with high coverage
WHO has set a vaccination target of 40 per cent population of every country by end-2021 and 70 per cent by mid-2022
Making COVID-19 vaccines in Africa: Advances and sustainability issues
Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities
The global approach to vaccine equity is failing: Additional steps that would help
The fight for vaccine equity needs to stop looking to multilateral institutions for permission and instead focus on the policy tools that are …
Is WHO nod for China’s Sinovac a domino effect of COVID-19 second wave in India?
The process of approval has become slower since Pfizer and BioNTech received approval
Everyone DOESN’T need booster jabs of COVID-19 vaccines: Lancet study (but are the rich countries reading?)
Access to vaccination has been vastly inequal; Booster doses in developed countries will further squeeze out low, mid-income …
COVID-19 vaccines for all: Why COVAX is not working
The initiative to deliver COVID-19 vaccines to the poorest countries has not succeeded in its goal so far due to over-dependence on a few …
Kenya’s COVID-19 vaccine rollout has got off to a slow start: The gaps, and how to fix them
Kenya is currently accessing vaccines exclusively through the COVAX facility, and yet supply to this initiative has been dogged by vaccine …